REGULATION OF ENDOGENOUS ERYTHROPOIETIN LEVELS IN ANEMIA ASSOCIATED WITH MYELODYSPLASTIC SYNDROMES

被引：0
|
作者：
VADHANRAJ, S [1 ]
HITTELMAN, WN [1 ]
LEPEZUNIGA, JL [1 ]
GUTTERMAN, JU [1 ]
BROXMEYER, HE [1 ]
机构：
[1] INDIANA UNIV,SCH MED,INDIANAPOLIS,IN 46202
来源：
BLOOD | 1990年 / 75卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1749 / 1750
页数：2
相关论文
共 50 条
  • [1] SERIAL CHANGES IN ENDOGENOUS ERYTHROPOIETIN LEVELS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND APLASTIC-ANEMIA UNDERGOING ERYTHROPOIETIN TREATMENT
    YOSHIDA, Y
    ANZAI, N
    KAWABATA, H
    KOHSAKA, Y
    OKUMA, M
    [J]. ANNALS OF HEMATOLOGY, 1993, 66 (04) : 175 - 180
  • [2] Effect of androgen therapy and anemia on serum erythropoietin levels in patients with aplastic anemia and myelodysplastic syndromes
    Piedras, J
    Hernández, G
    López-Karpovitch, X
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1998, 57 (02) : 113 - 118
  • [3] VARIABILITY OF ENDOGENOUS ERYTHROPOIETIN LEVELS IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES
    Gurnari, C.
    Latagliata, R.
    Piciocchi, A.
    Fenu, S.
    Mancini, S.
    Fianchi, L.
    Criscuolo, M.
    Sarlo, C.
    Romano, A.
    Falconi, G.
    Niscola, P.
    Buccisano, F.
    Di Veroli, A.
    Breccia, M.
    Piccioni, A.
    Lo Coco, F.
    Voso, M. T.
    [J]. HAEMATOLOGICA, 2018, 103 : S45 - S46
  • [4] Effect of androgen therapy and anemia on serum erythropoietin levels in patients with aplastic anemia and myelodysplastic syndromes.
    Piedras, J
    Hernandez, G
    LopezKarpovitch, X
    [J]. BLOOD, 1996, 88 (10) : 2782 - 2782
  • [5] Erythropoietin for the anemia of low-risk myelodysplastic syndromes
    Fenaux, P
    Ades, L
    [J]. BLOOD, 2005, 106 (03) : 768 - 769
  • [6] Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes
    Konstantinidou, P
    Repoussis, P
    Georgopoulos, A
    Tsiara, S
    Bai, M
    Christou, L
    Bourantas, K
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1036 - 1036
  • [7] THE TREATMENT OF ANEMIA IN THE MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    BOWEN, D
    CULLIGAN, D
    JACOBS, A
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1991, 77 (03) : 419 - 423
  • [8] Association of amifostine and erythropoietin for the treatment of anemia in myelodysplastic syndromes.
    Musto, P
    Grossi, A
    Balestri, F
    Scalzulli, PR
    D'Arena, G
    Sanpaolo, MG
    Mantuano, SF
    Bodenizza, CA
    Falcone, A
    Rossi-Ferrini, P
    Carotenuto, M
    [J]. BLOOD, 2000, 96 (11) : 262B - 262B
  • [9] Combination of erythropoietin and thalidomide for the treatment of anemia in patients with myelodysplastic syndromes
    Musto, P
    Falcone, A
    Sanpaolo, G
    Bodenizza, C
    [J]. LEUKEMIA RESEARCH, 2006, 30 (04) : 385 - 388
  • [10] IMPROVEMENT OF ANEMIA BY RECOMBINANT ERYTHROPOIETIN IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND APLASTIC-ANEMIA
    BESSHO, M
    JINNAI, I
    MATSUDA, A
    SAITO, M
    HIRASHIMA, K
    [J]. INTERNATIONAL JOURNAL OF CELL CLONING, 1990, 8 (06): : 445 - 458
12345